Example: Heart Attack

Search clinical trials for: Paroxetine

Total 263 results

NCT03504475

Completed

Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

Conditions: Major Depressive Disorder; Obsessive-Compulsive Disorder; Panic Disorder; Social Anxiety Disorder; Generalized Anxiety Disorder
NCT03274752

Active, not recruiting

Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction

Conditions: Cardiac Remodeling; Myocardial Infarction
NCT01829919

Completed

Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women

Conditions: Postmenopausal Symptoms
NCT04311463

Completed

Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants

Conditions: Anxiety Disorders
NCT02681198

Completed

Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers

Conditions: Healthy
NCT01841502

Terminated

Interaction Between Paroxetine and Telaprevir

Conditions: Hepatitis C Infection; Depression
NCT01916200

Withdrawn

Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients

Conditions: Depressive Disorder
NCT01416220

Completed

Lithium Versus Paroxetine in Major Depression

Conditions: Major Depressive Disorder
NCT00406432

Completed

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

Conditions: Depressive Disorder
NCT00610610

Completed

Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome

Conditions: Fibromyalgia Syndrome
NCT02852577

Completed

Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine

Conditions: Panic Disorder; Agoraphobia
NCT01458626

Completed

Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement

Conditions: Major Depression
NCT00560612

Completed

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

Conditions: Stress Disorders, Post-Traumatic
NCT00184106

Completed

RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo

Conditions: Phobic Disorders
NCT00368303

Completed

A Local Register Study For Major Depression Of Paroxetine Controlled Release

Conditions: Depressive Disorder, Major; Major Depressive Disorder (MDD)
NCT00246441

Completed

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Conditions: Social Anxiety Disorder; Social Phobia; Alcohol Use Disorder; Alcohol Abuse; Alcohol Dependence
NCT01376271

Completed

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

Conditions: Social Phobia
NCT01159821

Completed

A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers

Conditions: Healthy
NCT03894085

Recruiting

Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment

Conditions: Anxiety Disorder; Obsessive-Compulsive Disorder
NCT01361308

Completed

Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)

Conditions: Postmenopausal Symptoms
NCT01101841

Completed

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

Conditions: Hot Flashes
NCT00516113

Completed

A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria

Conditions: Premenstrual Dysphoric Disorder; Premenstrual Syndrome
NCT00620581

Completed

Luteal Phase Administration of Paroxetine for the Treatment of PMDD

Conditions: Premenstrual Dysphoric Disorder
NCT04650542

Not yet recruiting

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

Conditions: Drug-drug Interaction
NCT00786188

Completed

Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause

Conditions: Hot Flashes